Abstract:Objective To examine the sex differences in prescribing patterns of psychotropic drugs and drug-induced side effects in schizophrenia patients in China. Methods Using the same design and a standardized protocol as in 2002 and 2006, the cross-sectional survey was conducted from July to August, 2012 in 45 psychiatric hospitals/centers in 10 provinces and municipalities in China. Inpatients and outpatients with schizophrenia were consecutively screened for eligibility for this study. Sociodemographic characteristics and prescription pattern were collected by using a modified questionnaire for the study. Data comparisons between male and female were performed with univariate analysis. Multiple logistic regression analysis was employed to determine the gender differences in prescription pattern and drug-induced side effects. Results The sample consisted of 2 260 male and 1 979 female patients. Univariate analyses showed that male patients were younger than female patients(t=5.398), having an earlier age at onset(t=5.662), higher percentage of being employed(χ2=31.597), and more negative symptoms(χ2=10.814)and aggressive behavior (χ2=5.816), more likely to receive clozapine (23.9%(472/1 979) vs. 28.5%(645/2 260),χ2=11.955), higher antipsychotic doses(476 mg vs. 514 mg,F=14.003), less use of antidepressants (7.9%(156/1 979) vs. 6.0%(136/2 260),χ2=5.722)and benzodiazepines(23.9%(472/1 979)vs. 20.0%(451/2 260),χ2=9.396), more frequent tardive dyskinesia(1.3%(25/1 979)vs. 2.1%(47/2 260),χ2=4.212)and less weight gain(11.0%(218/1 979)vs. 7.7%(173/2 260),χ2=14.233)and prolactin elevation(3.2%(63/1 979)vs. 1.7%(39/2 260),χ2=9.548;all P<0.05). In multivariate analyses, greater rate of clozapine use (OR=1.268,P=0.001), less rate of benzodiazepines use(OR=0.841,P=0.025) and antidepressants(OR=0.78,P=0.045),higher rate of tardive dyskinesia(OR=1.879,P=0.014)and less weight gain (OR=0.669,P=0.001) and prolactin elevation (OR=0.527,P=0.003) were independently associated with the male sex. Conclusion Gender is one of the independent contributors to psychotropic prescription pattern and side effects of antipsychotics in Chinese schizophrenia patients. Gender differences should be given more attention in research and clinical practice.

Present Survey on Antipsychotic Medications to the Patients with Schizophrenia in Hebei Province

Survey on Psychotropic Drug Used in Depression in HeBei Province

From strict quarantine to an optimized policy: Are we psychologically prepared?

Trends of Antipsychotic Drugs Use in Schizophrenia Patients from Hebei Province

The second cross-sectional study on antipsychotic drug patterns of schizophrenia in China

Antipsychotic drug patterns of schizophrenia in China:a cross-sectioned study

A present survey on clinical medication of bipolar disorder among provincial,municipal, and county three-class hospitals in Hebei Province

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China.

Survey on Medication Treatment Patterns in 125 Patients with Bipolar Disorder

Investigation and analysis on the frequency of anti -psychotropic drugs of all grades of mental health institutions in Hebei

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

Investigation of Clinical Application of Antipsychotic Drugs for Psychiatric Inpatients

Patterns of Antipsychotic Prescriptions in Patients with Schizophrenia in China: A National Survey

A survey of antipsychotics combination therapy and its related factors in China 2006

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Sex Differences in Pharmacotherapy of Schizophrenia:Findings from National Survey 2012 on Use of Psychotropic Medications

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

A survey of antipsychotic usage in treatment of schizophrenia in China 2006

Antipsychotic prescription patterns among schizophrenia patients in Guangdong Province, China's 686 program: A retrospective study

Adjunctive Antidepressant Use In Schizophrenia In China: A National Survey (2002-2012)

Investigation on clozapine use in patients with schizophrenia